down arrow

Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
817.95
40.95 (5.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.69 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Net Sales
254.52
215.20
182.22
392.14
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
254.52
215.20
182.22
392.14
Raw Material Cost
113.13
106.08
82.65
171.24
Purchase of Finished goods
9.41
0.86
0.03
3.30
(Increase) / Decrease In Stocks
-0.83
0.21
-7.28
-6.23
Employee Cost
31.10
23.57
22.08
14.31
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
47.22
38.79
36.10
54.07
Total Expenditure (Excl Depreciation)
200.02
169.51
133.58
236.70
Operating Profit (PBDIT) excl Other Income
54.50
45.69
48.64
155.44
Other Income
1.15
1.25
1.48
1.91
Operating Profit (PBDIT)
55.65
46.94
50.12
157.35
Interest
7.38
7.33
4.35
1.89
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
48.27
39.61
45.77
155.46
Depreciation
13.21
14.49
10.53
7.93
Profit Before Tax
35.06
25.11
35.26
147.53
Tax
9.74
5.82
8.57
37.72
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
25.32
19.30
26.68
109.80
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
25.32
19.30
26.68
109.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.01
0.03
0.07
0.03
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
25.36
19.35
26.66
109.84
Equity Capital
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
Diluted Earnings per share
8.21
7.39
6.82
15.2
Operating Profit Margin (Excl OI)
21.41%
21.23%
26.69%
39.64%
Gross Profit Margin
18.97%
18.41%
25.12%
39.64%
PAT Margin
9.95%
8.97%
14.64%
28.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 18.27% vs 18.10% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is 31.06% vs -27.42% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 19.28% vs -6.06% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 0.68% vs 68.51% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023

Compare Nine Monthly Results Of Kwality Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
254.52
9,199.93
-8,945.41
-97.23%
Other Operating Income
0.00
0.00
0.00
Total Operating income
254.52
9,199.93
-8,945.41
-97.23%
Raw Material Cost
113.13
1,471.08
-1,357.95
-92.31%
Purchase of Finished goods
9.41
1,244.57
-1,235.16
-99.24%
(Increase) / Decrease In Stocks
-0.83
-93.01
92.18
99.11%
Employee Cost
31.10
1,989.92
-1,958.82
-98.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
47.22
2,225.77
-2,178.55
-97.88%
Total Expenditure (Excl Depreciation)
200.02
6,838.33
-6,638.31
-97.08%
Operating Profit (PBDIT) excl Other Income
54.50
2,361.60
-2,307.10
-97.69%
Other Income
1.15
287.35
-286.20
-99.60%
Operating Profit (PBDIT)
55.65
2,648.95
-2,593.30
-97.90%
Interest
7.38
238.94
-231.56
-96.91%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
48.27
2,410.01
-2,361.74
-98.00%
Depreciation
13.21
405.66
-392.45
-96.74%
Profit Before Tax
35.06
2,007.79
-1,972.73
-98.25%
Tax
9.74
427.80
-418.06
-97.72%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
25.32
1,576.55
-1,551.23
-98.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
25.32
1,576.55
-1,551.23
-98.39%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.01
-7.70
7.71
100.13%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
25.36
1,570.19
-1,544.83
-98.38%
Equity Capital
10.38
40.06
-29.68
-74.09%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
18.97%
26.20%
0.00
-7.23%
PAT Margin
9.95%
17.14%
0.00
-7.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 254.52 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 18.27% vs 18.10% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 25.36 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 31.06% vs -27.42% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 54.50 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 19.28% vs -6.06% in Dec 2023

Nine Monthly - Interest
Interest 7.38 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 0.68% vs 68.51% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.41%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023